| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $767.0M | +1.7% | -5.0% |
| Cost of Revenue | $631.0M | +2.3% | -3.8% |
| R&D Expense | $1.0M | +0.0% | +0.0% |
| SG&A Expense | $96.0M | -4.0% | -16.5% |
| Interest Expense | $12.0M | +0.0% | -25.0% |
| Pre-tax Income | -$38.0M | +0.0% | -123.9% |
| Income Tax | $8.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $248.0M | -9.8% | -36.9% |
| Accounts Receivable | $488.0M | +6.6% | -7.6% |
| Current Assets | $1.15B | +0.6% | -20.1% |
| Total Assets | $2.50B | +0.5% | -12.0% |
| Current Liabilities | $702.0M | +0.7% | -15.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$112.0M | — | — |
| Capital Expenditures | $44.0M | — | — |
| Investing Cash Flow | -$6.0M | — | — |
| Financing Cash Flow | $0 | — | — |
| Free Cash Flow | -$156.0M | — | — |
| +300.0% |
| -77.8% |
| Net Income | -$46.0M | -15.0% | -137.4% |
| EPS (Basic) | -$0.30 | -15.4% | -140.0% |
| EPS (Diluted) | -$0.30 | -15.4% | -141.7% |
| $1.64B |
| +4.6% |
| -9.7% |
| Stockholders' Equity | $717.0M | -7.7% | -18.2% |